Organization
INIBIC-Hospital Universitario A Coruña, Galicia, Spain
2 abstracts
Abstract
APREMILAST IS ASSOCIATED WITH LONG-TERM (4-YEAR) DAS-28 (CRP) REMISSION AND IMPROVEMENTS IN SKIN DISEASE: RESULTS FROM A PHASE III STUDY IN DMARD/BIOLOGIC-EXPERIENCED PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS Org: University Hospital Southampton, Southampton, United Kingdom, INIBIC-Hospital Universitario A Coruña, Galicia, Spain, Bakersfield Dermatology, Bakersfield, Celgene Corporation, Summit, University of Massachusetts Medical School, Worcester, United States,
Abstract
APREMILAST, AN ORAL PHOSPHODIESTERASE 4 INHIBITOR, IN PATIENTS WITH PSORIATIC ARTHRITIS INCLUDING CURRENT SKIN INVOLVEMENT: RESULTS OF A PHASE 3, RANDOMIZED, CONTROLLED TRIAL Org: University of Massachusetts Medical School, Worcester, United States, INIBIC-Hospital Universitario A Coruña, Galicia, Spain, Bakersfield Dermatology, Bakersfield, United States, Celgene Corporation, Warren, United States, University Hospital Southampton, Southampton, United Kingdom,